TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations-Reference-Cited by-同舟云学术

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations

Published:2020-08-10 Issue:9 Volume:130 Page:4771-4790
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Dodhiawala Paarth B.^ORCID,Khurana Namrata,Zhang Daoxiang,Cheng Yi^ORCID,Li Lin,Wei Qing,Seehra Kuljeet,Jiang Hongmei,Grierson Patrick M.,Wang-Gillam Andrea,Lim Kian-Huat^ORCID

Funder

National Institutes of Health

American Cancer Society

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/137660/files/pdf

Reference65 articles.

1. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

2. KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer

3. Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy

4. NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer;Algül;Int J Gastrointest Cancer,2002

5. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells;Wang;Clin Cancer Res,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS;Cell Reports;2024-09

2. IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial–mesenchymal transition;Cell Communication and Signaling;2024-08-08

3. MAP3K8 is a potential therapeutic target in airway epithelial inflammation;Journal of Inflammation;2024-07-19

4. Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer;Frontiers in Hematology;2024-02-15

5. Sleep deprivation alleviates depression-like behaviors in mice via inhibiting immune and inflammatory pathways and improving neuroplasticity;Journal of Affective Disorders;2023-11